Membrane transporter genes predict chemoradiotherapy response in patients with cervical cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identified ATP1B3 and SLCO1B3 gene expression as accurate predictors of chemoradiotherapy response in cervical cancer. This discovery offers potential for personalized treatment strategies and improved patient outcomes.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Cervical cancer is a significant global health concern, with resistance to chemoradiotherapy being a major clinical challenge.
- Membrane transport-related genes, including efflux transporters (e.g., P-glycoprotein) and solute carriers, are implicated in chemoradiotherapy resistance.
- Identifying predictive biomarkers is crucial for developing personalized treatment strategies in cervical cancer.
Purpose Of The Study
- To identify specific membrane transport-related gene expression profiles as potential biomarkers for predicting chemoradiotherapy response in cervical cancer.
- To evaluate the predictive accuracy of identified gene signatures for treatment outcomes.
Main Methods
- Cervical cancer biopsies from 31 patients (21 responders, 10 non-responders) were analyzed.
- Gene expression profiling was performed using Illumina sequencing.
- Differential gene expression analysis and decision tree methods were employed to identify predictive biomarkers.
Main Results
- Two distinct gene expression profiles were identified, correlating with treatment response.
- The expression profiles of ATP1B3 and SLCO1B3 accurately classified patients as responders or non-responders with 90% accuracy.
- These genes represent potential predictive biomarkers for chemoradiotherapy response.
Conclusions
- A candidate gene signature comprising ATP1B3 and SLCO1B3 demonstrates significant predictive value for chemoradiotherapy response in cervical cancer.
- These findings support the potential for ATP1B3 and SLCO1B3 as biomarkers for personalized treatment selection.
- Further validation is warranted to integrate these biomarkers into clinical practice.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...